Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

2.7K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.7K
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

5.7K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.7K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

107
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
107
Antimicrobial Proteins01:23

Antimicrobial Proteins

2.1K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
2.1K
Pharmacovigilance01:19

Pharmacovigilance

934
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
934
Nursing Clinical Information System01:27

Nursing Clinical Information System

845
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
845

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predisposition to Ascaris lumbricoides reinfection in the Geshiyaro project in southern Ethiopia.

Transactions of the Royal Society of Tropical Medicine and Hygiene·2026
Same author

Cefazolin for Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia.

The New England journal of medicine·2026
Same author

Immunogenicity and safety of co-administration of a recombinant shingles vaccine with an mRNA COVID-19 or adjuvanted influenza vaccine: a randomised controlled trial.

The Journal of infection·2026
Same author

Vaccine cold chain and understanding what underpins vaccine security for vaccine preventable diseases.

BMJ medicine·2026
Same author

Heatstroke mortality in a warming world.

The Lancet. Public health·2026
Same author

Ethnicity and sub-Saharan African representation in the emergency development of covid-19 vaccines.

BMJ medicine·2025

Related Experiment Video

Updated: Aug 9, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

416

Informing antimicrobial stewardship with explainable AI.

Massimo Cavallaro1,2, Ed Moran3, Benjamin Collyer4

  • 1School of Life Sciences and Mathematics Institute, University of Warwick, Coventry, United Kingdom.

PLOS Digital Health
|February 22, 2023
PubMed
Summary

This study demonstrates how an artificial intelligence system can predict bacterial antibiotic resistance while providing clear explanations for its decisions. By using patient history and lab data, the model helps doctors choose more effective treatments, potentially reducing errors in prescribing medication.

Keywords:
clinical decision supportbacterial resistancepredictive analyticshealthcare transparency

Frequently Asked Questions

More Related Videos

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
05:30

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

148
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.0K

Related Experiment Videos

Last Updated: Aug 9, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

416
Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
05:30

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

148
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.0K

Area of Science:

  • Infectious disease management within antimicrobial stewardship
  • Explainable AI applications in clinical informatics

Background:

No prior work had resolved the tension between high-performing predictive models and the need for clinical transparency. Complex algorithms frequently operate as black boxes, limiting their utility in high-stakes medical environments. Clinicians often hesitate to integrate automated tools when the reasoning behind a specific output remains hidden. This uncertainty drove the development of interpretable machine learning frameworks to bridge the gap between performance and trust. Prior research has shown that opaque systems face significant barriers to widespread adoption in hospital settings. Concerns regarding patient safety and legal accountability further complicate the deployment of advanced computational diagnostics. That gap motivated the investigation of methods that offer both predictive power and human-readable justifications. This study addresses these challenges by evaluating a transparent approach to antibiotic resistance forecasting.

Purpose Of The Study:

The study aims to evaluate whether explainable artificial intelligence can improve antibiotic resistance prediction while maintaining clinical transparency. Researchers sought to address the common conflict between high-performing predictive models and the requirement for intuitive explanations. The project investigates if providing justifications for algorithmic outputs can foster trust among healthcare professionals. A significant motivation was the need to reduce risks associated with mismatched antibiotic treatments in hospital settings. The authors aimed to demonstrate that complex models do not necessarily need to function as opaque black boxes. By incorporating interpretability tools, the team explored ways to align machine predictions with established medical expertise. This work addresses the critical barrier of clinician skepticism regarding automated diagnostic tools. The researchers intended to show that confidence attribution and clear reasoning can facilitate the broader integration of digital health technologies.

Main Methods:

The review approach involved analyzing a comprehensive dataset containing hospital admission records and bacterial susceptibility profiles. Researchers utilized a gradient boosted decision tree algorithm to process patient characteristics and historical treatment data. To ensure transparency, the team integrated a Shapley explanation model alongside the primary predictive framework. This combination allowed for the attribution of specific confidence scores to each generated forecast. The study design focused on evaluating the model's ability to minimize mismatched antibiotic prescriptions. Investigators compared the automated suggestions against actual clinical decisions recorded in the hospital database. This methodology prioritized the alignment of algorithmic associations with established medical knowledge from health specialists. The systematic evaluation confirmed the feasibility of generating human-readable justifications for complex computational outputs.

Main Results:

The primary finding indicates that the AI-based system substantially decreases the risk of mismatched treatment compared to observed clinical prescriptions. The model successfully links patient-specific variables, such as admission data and culture results, to accurate resistance predictions. Associations identified by the Shapley values show broad consistency with expectations held by experienced health specialists. By providing clear justifications, the system addresses the inherent trade-off between predictive accuracy and model transparency. The researchers report that the ability to assign confidence levels to predictions enhances the reliability of the automated tool. These results demonstrate that interpretability models can effectively bridge the gap between advanced computation and clinical trust. The findings highlight that automated systems can offer actionable insights while maintaining alignment with established medical standards. This performance suggests that such frameworks are suitable for supporting complex decision-making in hospital environments.

Conclusions:

The authors propose that providing clear justifications for algorithmic predictions facilitates greater acceptance of automated tools in clinical practice. Their findings suggest that integrating interpretability models helps align machine outputs with established medical expertise. The researchers conclude that these systems effectively lower the probability of inappropriate medication choices for patients. This synthesis indicates that transparency is a key factor in overcoming skepticism toward digital health solutions. The study demonstrates that confidence scores and feature attribution enhance the utility of predictive analytics. These results imply that clinicians can better rely on computational support when the underlying logic is visible. The authors maintain that such frameworks represent a viable path forward for improving hospital-based infection management. Future efforts should focus on validating these interpretative techniques across diverse healthcare environments and patient populations.

The researchers propose that a gradient boosted decision tree combined with a Shapley explanation model predicts resistance. This approach identifies associations between patient characteristics and bacterial susceptibility, allowing the system to offer intuitive justifications for its specific drug recommendations.

The Shapley explanation model serves as the primary tool for interpretability. It assigns values to specific input features, such as historical treatments or culture results, enabling clinicians to visualize which factors most strongly influenced the model's prediction for a given patient.

The authors indicate that incorporating patient-specific data, including admission records and prior antibiotic history, is necessary for accurate resistance forecasting. These inputs allow the model to tailor its predictions to the unique clinical context of each individual hospital admission.

The researchers utilize a dataset linking hospital admissions to bacterial isolate susceptibilities and antibiotic prescriptions. This data type is essential for training the algorithm to recognize patterns in resistance and for evaluating the model's performance against actual clinical outcomes.

The study measures the effectiveness of the AI system by comparing its recommendations against observed clinical prescriptions. The researchers report that the model substantially reduces the risk of mismatched treatment compared to standard prescribing practices.

The authors claim that the ability to attribute confidence and provide clear explanations supports the wider adoption of AI in healthcare. They suggest that transparency helps mitigate concerns regarding liability and patient safety that currently hinder the integration of automated diagnostic tools.